APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
Background With the onset of prevention trials for individuals at high risk for Alzheimer disease, there is increasing need for accurate risk prediction to inform study design and enrollment, but available risk estimates are limited. We developed risk estimates for the incidence of mild cognitive im...
Main Authors: | Qian, Jing, Wolters, Frank J., Beiser, Alexa, Haan, Mary, Ikram, M. Arfan, Karlawish, Jason, Langbaum, Jessica B., Neuhaus, John M., Reiman, Eric M., Roberts, J. Scott, Seshadri, Sudha, Tariot, Pierre N., Woods, Beth McCarty, Betensky, Rebecca A., Blacker, Deborah |
---|---|
Other Authors: | Univ Arizona, Coll Med, Dept Psychiat |
Language: | en |
Published: |
PUBLIC LIBRARY SCIENCE
2017
|
Online Access: | http://hdl.handle.net/10150/623943 http://arizona.openrepository.com/arizona/handle/10150/623943 |
Similar Items
-
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
by: Jing Qian, et al.
Published: (2017-03-01) -
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
by: Galit Weinstein, et al.
Published: (2016-01-01) -
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.
by: Galit Weinstein, et al.
Published: (2019-01-01) -
Variation in blood pressure and long-term risk of dementia: A population-based cohort study.
by: Yuan Ma, et al.
Published: (2019-11-01) -
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
by: Saima Hilal, et al.
Published: (2018-06-01)